Delafloxacin is a fluoroquinolone antibiotic used in the treatment of acute bacterial skin and skin structure infections, as well as community-acquired bacterial pneumonia. As a dual-targeting agent, it… Read more


































Delafloxacin is a fluoroquinolone antibiotic used in the treatment of acute bacterial skin and skin structure infections, as well as community-acquired bacterial pneumonia. As a dual-targeting agent, it functions by inhibiting bacterial DNA gyrase and topoisomerase IV to prevent essential DNA replication. This category provides an extensive collection of Delafloxacin-related compounds, including the active pharmaceutical ingredient, diverse process-related and degradation impurities, and specific metabolites such as acyl glucuronides. Laboratories utilize these high-quality reference standards for critical analytical tasks, including impurity profiling, method validation, and routine quality control. Furthermore, stable isotope-labelled compounds are available to serve as internal standards in advanced bioanalytical techniques like LC-MS/MS, ensuring accurate quantification and reliable data during stability studies and regulatory compliance testing. These compounds are essential for verifying the identity, purity, and potency of drug substances throughout the pharmaceutical lifecycle.